UPDATE : Monday, September 7, 2020
상단여백
EU approvals for Samsung Bioepis push up share prices by Nam Doo-hyun 2017-09-18 14:45
‘Knowledge’ is core ability for bio industrialists, survey says by Nam Doo-hyun 2017-09-15 16:28
Experts call for overhauling bio industry promotion policy by Nam Doo-hyun 2017-09-15 15:39
New VC investments in bio, medical fields fall sharpest in H1 by Nam Doo-hyun 2017-09-13 13:23
China, Australia emerge as promising markets for medical equipment makers by Nam Doo-hyun 2017-09-12 17:40
라인
Brokerage analyzes profit-sharing structure of Celltrion group by Nam Doo-hyun 2017-09-12 16:55
Drugmakers adopt VR in sales, promotion by Nam Doo-hyun 2017-09-11 17:21
Experts stress need for drug treatments to control cholesterol by Nam Doo-hyun 2017-09-11 12:01
Investment into GMP facility needed to export bio medicines by Nam Doo-hyun 2017-09-11 11:59
Drugmakers introduce VR for diabetes therapy by Nam Doo-hyun 2017-09-06 17:12
라인
Papers related to stem cell therapy rising worldwide by Nam Doo-hyun 2017-09-06 16:45
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks by Nam Doo-hyun 2017-09-05 16:45
Survey tracks reasons Chinese come to Korea for cosmetic surgery by Nam Doo-hyun 2017-09-04 14:20
‘AI to boost success rates, effectiveness for clinical trials’ by Nam Doo-hyun 2017-08-28 14:34
Ferring’s offshoot swindled by email mimicking headquarter office by Nam Doo-hyun 2017-08-25 17:54
라인
Pharmaceutical sectors of major countries show mixed results by Nam Doo-hyun 2017-08-24 18:35
Quadrivalent influenza vaccines enter fierce sales competition by Nam Doo-hyun 2017-08-24 15:04
Bio firms blame small R&D spending for low technology by Nam Doo-hyun 2017-08-24 11:31
Triumeq aims to change HIV drug market with easy use by Nam Doo-hyun 2017-08-23 12:12
Celltrion’s move to main stock market draws investor concern by Nam Doo-hyun 2017-08-22 17:01
여백
여백
여백
Back to Top